Postoperative Chemotherapy for N2 Non–Small-Cell Lung Cancer: Conclusions Are Not Black and White, but Gray
Authors:
- Nasser H HannaNHNasser H Hanna
- Lawrence H EinhornLELawrence H Einhorn
- 10 December 2006
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (35) , 5611-5612
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results DatabaseJournal of Clinical Oncology, 2006
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Multimodality detection of multicentric breast cancerJournal of Clinical Oncology, 2005
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trialsThe Lancet, 1998